Park West Asset Management LLC Buys Shares of 300,000 Azenta, Inc. (NASDAQ:AZTA)

Park West Asset Management LLC purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 300,000 shares of the company's stock, valued at approximately $15,000,000. Park West Asset Management LLC owned 0.66% of Azenta at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Quarry LP purchased a new position in Azenta in the fourth quarter valued at about $110,000. Boothbay Fund Management LLC raised its position in shares of Azenta by 8.4% in the 4th quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock valued at $329,000 after purchasing an additional 509 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Azenta during the 4th quarter valued at approximately $3,925,000. Lord Abbett & CO. LLC acquired a new stake in shares of Azenta during the fourth quarter worth approximately $47,350,000. Finally, Syon Capital LLC acquired a new stake in Azenta in the fourth quarter valued at $359,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Stock Performance

Shares of NASDAQ AZTA traded down $0.11 during midday trading on Thursday, hitting $26.23. The company's stock had a trading volume of 789,087 shares, compared to its average volume of 652,159. Azenta, Inc. has a 1-year low of $24.06 and a 1-year high of $63.58. The firm's fifty day moving average price is $33.54 and its 200-day moving average price is $42.75. The firm has a market cap of $1.20 billion, a P/E ratio of -8.80 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, research analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on AZTA shares. Evercore ISI boosted their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC boosted their price objective on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a report on Thursday, February 6th. Stephens restated an "overweight" rating and set a $60.00 price objective on shares of Azenta in a research note on Thursday, January 2nd. Finally, TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.